{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T20:27:09Z","timestamp":1668889629027},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.leukres.2010.05.019","type":"journal-article","created":{"date-parts":[[2010,6,20]],"date-time":"2010-06-20T20:47:06Z","timestamp":1277066826000},"page":"1250-1251","source":"Crossref","is-referenced-by-count":5,"title":["Occurrences of opportunistic infections in chronic myelogenous leukemia patients treated with imatinib mesylate"],"prefix":"10.1016","volume":"34","author":[{"given":"Navin","family":"Anthony","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Shanks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Terebelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2010.05.019_bib1","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1182\/blood-2007-04-084814","article-title":"Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation","volume":"111","author":"Schade","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.05.019_bib2","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1182\/blood-2003-12-4266","article-title":"Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo","volume":"104","author":"Dietz","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.05.019_bib3","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1182\/blood-2004-07-2527","article-title":"Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner","volume":"105","author":"Seggewiss","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.05.019_bib4","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.4049\/jimmunol.178.4.2028","article-title":"Imatinib mesylate inhibits antigen-specific memory CD8 T cell responses in vivo","volume":"178","author":"Sinai","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2010.05.019_bib5","unstructured":"Imatinib Mesylate [package insert]. East Hanover (NJ): Novartis Pharmaceuticals Corporation; 2008."},{"key":"10.1016\/j.leukres.2010.05.019_bib6","first-page":"976","article-title":"Development of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate","volume":"9","author":"Mattiuzzi","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2010.05.019_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/14639230500236818","article-title":"Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment","volume":"47","author":"Ikeda","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2010.05.019_bib8","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1182\/blood-2003-07-2436","article-title":"EBV-positive cutaneous B-cell lymphoproliferative disease after imatinib mesylate","volume":"102","author":"Bekkenk","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.05.019_bib9","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/sj.leu.2403401","article-title":"Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro","volume":"18","author":"Cwynarski","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2010.05.019_bib10","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1182\/blood-2003-03-0975","article-title":"Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells","volume":"103","author":"Appel","year":"2004","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610002638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610002638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T02:51:31Z","timestamp":1544410291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212610002638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0145212610002638"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2010.05.019","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}